LLY•benzinga•
Barclays Maintains Overweight on Eli Lilly, Lowers Price Target to $975
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga